Mr. Mobeck is a seasoned corporate and operational finance executive with extensive experience in MedTech and technology organizations. Prior to joining EDAP, Ken served as Vice President of Finance and Investor Relations at medical device manufacturer Accuray Inc., a leading global radiation therapy company. During his tenure, he was responsible for driving several key initiatives tied to improving the company’s operating performance and strategic growth objectives.
Prior to joining Accuray, Ken served as Vice President, Finance with optical networking leader Lumentum where he helped raise $900M in debt financing to grow the business from $900M to $1.6B in only three years. Before Lumentum, he spent over two decades in positions with increasing levels of responsibility at some of Silicon Valley’s most innovative companies including Silicon Graphics, Hewlett Packard, KLA and Intel Corporation where he was involved in high scale growth, mergers & acquisitions and business transformation. Notably, while employed at KLA, he helped grow revenue from $1.3B to $2.7B over seven years. Ken holds an MBA and a BSC in Finance from the Leavey School of Business at Santa Clara University. Ken Mobeck was appointed CFO on January 1, 2024.
 

Dr. Lance Willsey was appointed as a member of the Board of Directors in December 2023. Dr. Lance Willsey, M.S., M.D. is a urologist who has an aggregate of 36 years of private and public board experience focused in the area of cancer diagnostics and therapeutics. He completed his surgical and urology training at the Massachusetts General Hospital and additional postgraduate training in the Steele Lab Harvard University and the Dana Farber Cancer Institute. Lance is a founding Partner of Healthcare fund DCF Capital. He also actively participated in boards as a Director of Exact Sciences from 1999 to 2009 and of Exelixis from 1997 to 2023. Lance helped guide the two companies through their IPO process as well as subsequent financings. He also has extensive experience in corporate governance having served on audit, compensation, finance and scientific advisory committees.